Literature DB >> 9009304

In vitro infection of smooth muscle cells by Chlamydia pneumoniae.

E Knoebel1, P Vijayagopal, J E Figueroa, D H Martin.   

Abstract

Recent observations have shown that both Chlamydia pneumoniae antigens and DNA may be found within atherosclerotic lesions. In this study, we evaluated the ability of C. pneumoniae to infect cells that make up atherosclerotic lesions, including endothelial cells, smooth muscle cells, and cholesterol-loaded smooth muscle cells. The organism readily infected rabbit, bovine, and human aortic smooth muscle cells. Cholesterol-loaded smooth muscle cells were even more susceptible to C. pneumoniae infection. Chlamydia trachomatis inefficiently infected smooth muscle cells, demonstrating that this is not a characteristic of all members of the genus Chlamydia. C. pneumoniae infected bovine endothelial cells poorly. This study demonstrates that C. pneumoniae readily infects one of the important types of cells found within atherosclerotic lesions, i.e., smooth muscle cells with and without cholesterol loading.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009304      PMCID: PMC176087          DOI: 10.1128/iai.65.2.503-506.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.

Authors:  Y F Zhou; M B Leon; M A Waclawiw; J J Popma; Z X Yu; T Finkel; S E Epstein
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

3.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; S P Wang; J T Grayston; D S Siscovick; D K Stewart; R A Kronmal; N S Weiss
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

5.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

6.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Authors:  A Shor; C C Kuo; D L Patton
Journal:  S Afr Med J       Date:  1992-09

7.  Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

Authors:  D Gospodarowicz; J Moran; D Braun; C Birdwell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

8.  Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.

Authors:  C A Gaydos; J T Summersgill; N N Sahney; J A Ramirez; T C Quinn
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

10.  Virus-induced atherosclerosis.

Authors:  C G Fabricant; J Fabricant; M M Litrenta; C R Minick
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA.

Authors:  D Palfrey; P J Cook; J A Smythe; G Y Lip; A V Hine
Journal:  Mol Pathol       Date:  1999-10

4.  Chlamydia pneumoniae in atheroma: consideration of criteria for causality.

Authors:  A Shor; J I Phillips; G Ong; B J Thomas; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

5.  Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae.

Authors:  J Rödel; M Woytas; A Groh; K H Schmidt; M Hartmann; M Lehmann; E Straube
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 6.  Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.

Authors:  Satoru Hirono; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.